An open-label, non-randomized study investigating the safety and efficacy of smallpox vaccine, LC16, as post-exposure prophylaxis for mpox

Mpox is an acute exanthematous disease caused by the monkeypox virus. Since May 2022, it has spread as a community-acquired infection, mainly in Europe and the United States, and urgent measures to prevent this infection were also required in Japan. In this study, we investigated the post-exposure p...

Descripción completa

Detalles Bibliográficos
Autores principales: Tomita, Noriko, Terada-Hirashima, Junko, Uemura, Yukari, Shimizu, Yosuke, Iwasaki, Haruka, Yano, Rina, Suzuki, Tetsuya, Saito, Sho, Okumura, Nobumasa, Sugiura, Wataru, Ohmagari, Norio, Ujiie, Mugen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2023
Materias:
Licensed Vaccines
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10416734/
https://www.ncbi.nlm.nih.gov/pubmed/37559375
http://dx.doi.org/10.1080/21645515.2023.2242219

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10416734/
https://www.ncbi.nlm.nih.gov/pubmed/37559375
http://dx.doi.org/10.1080/21645515.2023.2242219

Ejemplares similares